Resources such as the Society for Integrative Oncology and Cancer Choices offer valuable information for patients exploring integrative options. In addition to receiving my traditional cancer ...

Global music phenomenon Ado is ready to embark on a new world tour in 2025! After the success of her earlier Wish tour, the Japanese superstar, in collaboration with Crunchyroll, will retake the ...

will present new data on integrative oncology research and clinical trials at the 21st International Conference of the Society for Integrative Oncology taking place Oct. 25 to 27. Integrative ...

It also rebranded to Sio, but the new business fared no better in its new incarnation. AXO-Lenti-PD failed a phase 2 trial and was dropped from development earlier this year, prompting the ...

Popular Japanese singer Ado will be bringing her Hibana world tour to the Singapore Indoor Stadium on May 21, 2025, marking her first show here. Set to be one of the biggest world tours organised ...

Data supplied by Morningstar and accurate on Aug 31, 2023. It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of ...

design, sale and construction of residential dwellings and providing registered training courses through Registered Training Organisation which has now been discontinued.

XI'AN, China, Nov. 9, 2024 /PRNewswire/ -- On behalf of the organizing committee of the 2024 Chinese Congress on Holistic Integrative Oncology (CCHIO), we are very pleased to invite you to attend ...

Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2–Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP) Eligible patients were ...

Atezolizumab Plus Chemotherapy With or Without Bevacizumab in Advanced Biliary Tract Cancer: Clinical and Biomarker Data From the Randomized Phase II IMbrave151 Trial At the time of data lock, 204 ...

Application goes beyond data aggregation to help clinicians quickly see a longitudinal view of their patient’s history, spotlighting disease progression and helping to inform proactive ...